• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/9

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

9 Cards in this Set

  • Front
  • Back
MSAFP screening
Maternal Serum alpha-fetoprotein); most sensitive between 16-18 weeks. AFP is HIGH with neural tube (anencephaly, spina bifida) and body wall defects (gastroschisis, omphalocele); LOW in triosmies but alone not sensitive or specific and not diagnostic; need to know gestational age, twin status, maternal health, status (diabetes), and race
QUAD screening
(screens for 4 MSAFPs); this screen increases sensitivity for LOW MSAFP; only 1/50 fetuses who test positive have trisomy, but much better than MSAFP alones
Ultrasonography
non invasive, high resolution of fetal echocardiograms; accurately estimate fetal age; at 6 weeks embryo seen; conditions with subetweenle findings may be missed; some diseases: neural tube defects, body wall defects, major organ abnormalities, oligo or polyhydramnios (too much amniotic fluid), major limb abnormalities, growth disturbances
nuchal translucency
(thickening of neck in DS—found using ultrasound)
Genetic Amniocentesis
—invasive to obtain fetal cells; enough fluid after 14 weeks to perform safely; most often between 15-20 wks (before 24—termination possible); fetal loss <0.5%; trauma and infection
Transcervical Chorionic Villus Sampling
invasive technique to obetweenain fetal cells, study chromosomes, DNA or biochemical profile of fetus; most often performed 10-13 wks but can be done as early as 9 weeks and any time after 13 weeks; fetal loss rate ~1%; risk of limb abnormalities (if done <10 wks) and infection
Percutaneous Umbilical Blood
sampling, perhaps the most invasive procedure to obetweenain fetal blood cells; study chromosomes, DNA, blook chemistries or biochem; needle under ultrasound guidance to obetweenain blood from umbilical vein; fetal loss rate 2%; rarely indicated needed or used except in special circumstances where amniocentesis or CVS not available
some indications for offering amniocentesis or chorionic villus sampling
: advanced maternal age, abnormal maternal serum marker test; family history of chromosome abnormality, genetic disease detectable by biochemical or DNA analysis, concerns of patient
Pre implantation genetic diagnosis (PGD):
Molecular Dx at 8-cell stage; implant unaffected embryos; requires IVF and is expensive.